Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital
Event:
EuroPrevent 2017
Topic:
Lipids
Session:
Diabetes/ Lipids/Obesity/Nutrition_Part 2
